Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of November 20, 2024 is 5.25.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-11-19 |
153.00 |
|
5.25 |
| 2024-09-30 |
162.06 |
$29.14 |
5.56 |
| 2024-06-30 |
145.06 |
$29.72 |
4.88 |
| 2024-03-31 |
155.72 |
$29.09 |
5.35 |
| 2023-12-31 |
153.13 |
$28.57 |
5.36 |
| 2023-09-30 |
150.96 |
$29.59 |
5.10 |
| 2023-06-30 |
159.29 |
$29.41 |
5.42 |
| 2023-03-31 |
148.04 |
$27.27 |
5.43 |
| 2022-12-31 |
167.54 |
$29.39 |
5.70 |
| 2022-09-30 |
153.95 |
$28.51 |
5.40 |
| 2022-06-30 |
166.16 |
$29.04 |
5.72 |
| 2022-03-31 |
164.86 |
$28.41 |
5.80 |
| 2021-12-31 |
158.11 |
$28.16 |
5.62 |
| 2021-09-30 |
148.28 |
$26.69 |
5.55 |
| 2021-06-30 |
150.36 |
$26.44 |
5.69 |
| 2021-03-31 |
149.07 |
$25.01 |
5.96 |
| 2020-12-31 |
141.87 |
$24.04 |
5.90 |
| 2020-09-30 |
133.27 |
$24.49 |
5.44 |
| 2020-06-30 |
125.05 |
$23.92 |
5.23 |
| 2020-03-31 |
115.80 |
$23.28 |
4.97 |
| 2019-12-31 |
127.98 |
$22.59 |
5.67 |
| 2019-09-30 |
112.73 |
$22.13 |
5.10 |
| 2019-06-30 |
121.36 |
$23.01 |
5.27 |
| 2019-03-31 |
120.97 |
$22.20 |
5.45 |
| 2018-12-31 |
110.95 |
$22.44 |
4.94 |
| 2018-09-30 |
118.03 |
$24.09 |
4.90 |
| 2018-06-30 |
102.97 |
$23.45 |
4.39 |
| 2018-03-31 |
107.95 |
$23.58 |
4.58 |
| 2017-12-31 |
116.95 |
$22.43 |
5.21 |
| 2017-09-30 |
108.17 |
$27.55 |
3.93 |
| 2017-06-30 |
109.37 |
$26.78 |
4.08 |
| 2017-03-31 |
102.29 |
$26.10 |
3.92 |
| 2016-12-31 |
94.01 |
$26.02 |
3.61 |
| 2016-09-30 |
95.73 |
$26.73 |
3.58 |
| 2016-06-30 |
97.65 |
$26.47 |
3.69 |
| 2016-03-31 |
86.49 |
$26.40 |
3.28 |
| 2015-12-31 |
81.52 |
$25.82 |
3.16 |
| 2015-09-30 |
73.54 |
$25.86 |
2.84 |
| 2015-06-30 |
76.18 |
$25.69 |
2.97 |
| 2015-03-31 |
78.07 |
$24.45 |
3.19 |
| 2014-12-31 |
80.59 |
$25.06 |
3.22 |
| 2014-09-30 |
81.61 |
$27.31 |
2.99 |
| 2014-06-30 |
79.56 |
$27.65 |
2.88 |
| 2014-03-31 |
74.19 |
$27.08 |
2.74 |
| 2013-12-31 |
68.68 |
$26.25 |
2.62 |
| 2013-09-30 |
64.56 |
$24.75 |
2.61 |
| 2013-06-30 |
63.47 |
$24.75 |
2.56 |
| 2013-03-31 |
59.81 |
$23.85 |
2.51 |
| 2012-12-31 |
51.02 |
$23.33 |
2.19 |
| 2012-09-30 |
49.72 |
$23.08 |
2.15 |
| 2012-06-30 |
48.31 |
$21.97 |
2.20 |
| 2012-03-31 |
46.71 |
$22.35 |
2.09 |
| 2011-12-31 |
46.04 |
$20.95 |
2.20 |
| 2011-09-30 |
44.30 |
$22.52 |
1.97 |
| 2011-06-30 |
45.86 |
$22.67 |
2.02 |
| 2011-03-31 |
40.49 |
$21.86 |
1.85 |
| 2010-12-31 |
41.89 |
$20.66 |
2.03 |
| 2010-09-30 |
41.61 |
$20.85 |
2.00 |
| 2010-06-30 |
39.29 |
$19.19 |
2.05 |
| 2010-03-31 |
42.98 |
$19.19 |
2.24 |
| 2009-12-31 |
42.14 |
$18.37 |
2.29 |
| 2009-09-30 |
39.52 |
$18.27 |
2.16 |
| 2009-06-30 |
36.58 |
$16.79 |
2.18 |
| 2009-03-31 |
33.57 |
$15.87 |
2.12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$368.366B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
